NAIROBI, Kenya – The sudden freezing of US aid to malaria projects comes as deadly new variants are spreading in Africa and could have a devastating impact, the head of a major NGO told AFP.
The US government has provided some 40 percent of the annual funding globally for control and research into a disease that causes more than 600,000 deaths from 250 million cases each year — mostly in Africa.
That funding, of up to $1 billion a year, is now frozen as part of President Donald Trump’s plan to axe foreign aid.
“We did try to anticipate in advance of this, but I think even our worst case scenarios have been surpassed,” said James Tibenderana, chief executive of the London-based Malaria Consortium that runs projects around the world.
The Malaria Consortium has already been forced to fire staff working on a program in Mozambique and halt a program in Asia training people to monitor and control mosquitoes.
Only five percent of its funding comes from the US government, but Tibenderana said US cuts would hit the entire sector.
“It’s just so disruptive, so sudden,” he said.
He highlighted that it came at a moment when the first signs of drug- and insecticide-resistance had started to emerge.
“The clock is ticking for drug resistance in Africa,” he said.
“The early signs of resistance to the artemisinin-based combination therapy medicine, which is the mainstay of treatment for malaria, are emerging.”
He pointed to reports from Eritrea, Ethiopia, South Sudan, Sudan and Uganda.
US-funded organisations have been the major player in monitoring this emergence through genome-mapping and drug-effectiveness studies.
Without them, it will be “hard to detect at the scale that was possible with US government funding”, said Tibenderana.
It also comes as an invasive mosquito species from Asia — Anopheles stephensi — has started spreading in East Africa.
It thrives in urban areas and is immune to insecticide, potentially putting an additional 126 million people in Africa’s cities at risk of malaria, according to one 2020 study.
“The invasion and spread of Anopheles stephensi has the potential to change the malaria landscape in Africa and reverse decades of progress we’ve made towards malaria control,” Meera Venkatesan, who was then malaria division chief for USAID, told AFP in November.
